We are live on
!
Find out more
SCM
Stevens Capital Management Portfolio holdings
AUM
$649M
1-Year Est. Return
27.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.44%
1 Year Est. Return
+27.37%
3 Year Est. Return
+49.81%
5 Year Est. Return
+67%
10 Year Est. Return
+208.35%
AUM
$2.24B
AUM Growth
-$107M
(-4.6%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-6.17%
Top 10 Holdings %
Top 10 Hldgs %
13.17%
Holding
955
New
308
Increased
134
Reduced
160
Closed
350
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$31.3M |
| 2 |
Merck
MRK
|
+$28.9M |
| 3 |
Morgan Stanley
MS
|
+$28.2M |
| 4 |
Verizon
VZ
|
+$27.6M |
| 5 |
Johnson & Johnson
JNJ
|
+$23.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$22.4M |
| 2 |
Duke Energy
DUK
|
+$22M |
| 3 |
Cognizant
CTSH
|
+$19.2M |
| 4 |
Fidelity National Information Services
FIS
|
+$19M |
| 5 |
Eaton
ETN
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.11% |
| 2 | Healthcare | 14.85% |
| 3 | Industrials | 13.1% |
| 4 | Technology | 12.1% |
| 5 | Consumer Discretionary | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
JB Hunt Transport Services
JBHT
$26.4B
| $2.43M | 0.11% |
26,620
-74,778
| -74% | -$7.06M |
|
227
Radian Group
RDN
$5.18B
| $2.39M | 0.11% |
+104,470
| New | +$2.38M |
|
228
Paychex
PAYX
$41.1B
| $2.38M | 0.11% |
+28,977
| New | +$2.44M |
|
229
UBS Group
UBS
$172B
| $2.36M | 0.11% |
198,982
| – | – |
|
230
Helen of Troy
HELE
$658M
| $2.34M | 0.1% |
17,907
+6,121
| +52% | +$801K |
|
231
nVent Electric
NVT
$24.1B
| $2.33M | 0.1% |
93,822
+54,241
| +137% | +$1.4M |
|
232
East-West Bancorp
EWBC
$17.8B
| $2.28M | 0.1% |
48,708
-38,826
| -44% | -$1.86M |
|
233
Snap-on
SNA
$21.1B
| $2.27M | 0.1% |
+13,721
| New | +$2.23M |
|
234
Exelixis
EXEL
$14B
| $2.25M | 0.1% |
105,097
+1,920
| +2% | +$40.2K |
|
235
Insperity
NSP
$1.92B
| $2.25M | 0.1% |
18,379
+7,169
| +64% | +$864K |
|
236
Telephone and Data Systems
TDS
$3.83B
| $2.24M | 0.1% |
73,639
+56,048
| +319% | +$1.75M |
|
|
IBKC
237
DELISTED
IBERIABANK Corp
IBKC
| $2.24M | 0.1% |
29,510
-1,441
| -5% | -$109K |
|
238
Valmont Industries
VMI
$9.61B
| $2.23M | 0.1% |
+17,575
| New | +$2.19M |
|
239
Keurig Dr Pepper
KDP
$41B
| $2.17M | 0.1% |
75,212
+64,035
| +573% | +$1.82M |
|
240
RenaissanceRe
RNR
$13.7B
| $2.17M | 0.1% |
12,204
+1,555
| +15% | +$256K |
|
|
INFO
241
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $2.17M | 0.1% |
+34,089
| New | +$1.96M |
|
242
Invesco
IVZ
$13.3B
| $2.15M | 0.1% |
+105,210
| New | +$2.18M |
|
243
Cognex
CGNX
$10.2B
| $2.14M | 0.1% |
44,659
+28,670
| +179% | +$1.38M |
|
244
HDFC Bank
HDB
$119B
| $2.12M | 0.09% |
+65,160
| New | +$1.96M |
|
245
Labcorp
LH
$24.7B
| $2.12M | 0.09% |
+14,245
| New | +$1.99M |
|
|
AMTD
246
DELISTED
TD Ameritrade Holding Corp
AMTD
| $2.1M | 0.09% |
42,168
-27,632
| -40% | -$1.43M |
|
247
EPR Properties
EPR
$4.85B
| $2.09M | 0.09% |
+28,058
| New | +$2.19M |
|
|
TCO
248
DELISTED
Taubman Centers Inc.
TCO
| $2.09M | 0.09% |
+51,092
| New | +$2.46M |
|
249
Popular Inc
BPOP
$10.9B
| $2.07M | 0.09% |
38,128
+13,833
| +57% | +$756K |
|
250
iShares MSCI Emerging Markets ETF
EEM
$28.6B
| $2.06M | 0.09% |
+48,124
| New | +$2.04M |
|
Similar funds
CCA
HPIA
GAMA
TWP
ACA
CAAM
RK
PCM
Stevens Capital Management's Q2 2019 Portfolio in Review
As of Q2 2019, Stevens Capital Management held 955 positions worth $2.24B, down 4.6% from $2.34B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Stevens Capital Management withdrew a net $138M in Q2 2019, closing 350 positions and reducing 160 holdings. Its most notable exit was Cognizant, an estimated $19.2M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Stevens Capital Management opened a new position in Merck worth $30.2M.
- Stevens Capital Management's largest Q2 2019 buy was Merck: 377,581 shares worth $30.2M.
- Stevens Capital Management added most to Eli Lilly in Q2 2019, an estimated $31.3M increase.
- Stevens Capital Management's biggest Q2 2019 reduction was CME Group, cutting an estimated $22.4M.
- Stevens Capital Management fully exited Cognizant in Q2 2019, selling an estimated $19.2M.
- Stevens Capital Management's ten largest holdings make up 13% of its $2.24B portfolio in Q2 2019.
- Stevens Capital Management opened 308 new positions and closed 350 in Q2 2019.
- Stevens Capital Management's portfolio value fell 4.6% quarter-over-quarter to $2.24B.
Based on Stevens Capital Management's 13F filing for Q2 2019, filed 31 Jul 2019.